NeuroOne Medical Tech (NASDAQ:NMTC) just reported results for the third quarter of 2024.
- NeuroOne Medical Tech reported earnings per share of -10 cents. This met the analyst estimate for EPS of -10 cents.
- The company reported revenue of $825,776.
- This was 58.71% worse than the analyst estimate for revenue of $2.00 million.